跳至主要内容
临床试验/NCT05040204
NCT05040204招募中1 期

The Effects of Dietary Supplementation on Serum Protein Glycosylation

University of California, Davis2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2022年6月23日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
招募中
入组人数
44
试验地点
2
主要终点
Characterize Immunoglobulin fragment crystallization modifications

研究概览

简要总结

Two randomized double-blind placebo-controlled clinical studies to assess the effects of dietary glycan monomer supplementation on the immune system, especially antibody glycosylation in healthy adults. Immune profiling and glycoproteomics will be performed on serum isolated at these same time points.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult men/women (age 18-45) who are in general good health with Body Mass Index (BMI) range of 18.5-25

排除标准

  • Adults younger than 18 or older than 45 years of age
  • Women who are pregnant, actively nursing or have had a pregnancy within the last year
  • Women who are peri-menopausal or post-menopausal
  • Women with irregular menstrual cycles (more frequently than every 21 days or lasts longer than 8 days. Missed, early, or late periods are also considered signs of an irregular cycle)
  • Women on hormonal contraception, including birth control, hormonal intrauterine device, or contraceptive implant
  • Individuals with past medical history of an autoimmune condition or malignancy, excluding non-melanoma skin cancer
  • Individuals with cardiovascular, pulmonary, reproductive, endocrine, metabolic, neurologic, gastrointestinal, hematologic, or infectious diseases of any type
  • Individuals with diagnosis of galactosemia or congenital disorders of glycosylation
  • Individuals with phenylketonuria
  • Individuals currently taking prescription medications, or who have taken prescription medications within the last 3 months
  • Individuals currently taking over-the-counter medications
  • Individuals currently taking or who have taken supplements including herbal, protein or vitamin supplements in the last 3 months (e.g. whey protein, St. John's Wort, green tea supplements, biotin, creatine supplements), excluding multivitamins or essential vitamins
  • Individuals with BMI less than 18.5 or greater than 25
  • Individuals with prior history of severe food or drug allergic reactions
  • Individuals with allergic reaction or adverse reaction to shellfish, N-acetylglucosamine, galactose, Spirulina/chlorella/algae supplements, or arabinose containing compounds/foods/supplements
  • Individuals with first-degree relative with history of an autoimmune condition
  • Individuals with social history of current use of tobacco, alcohol or other drugs
  • Individuals with dietary restrictions (vegetarians are permitted to participate in the study) or atypical exercise patterns, or to whom any of the following dietary habits or characteristics apply (the following exclusion criteria are placed to minimize variability in diet/exercise patterns in our pilot study population):
  • Actively dieting or trying to lose weight
  • Vegan diet
  • Consume equal to or greater than 2 cups of tea a day
  • Consume equal to or greater than 4 cups of coffee a day
  • Consume equal to or greater than 3 cups of fruit juice a day
  • Practice intensive exercise patterns (marathon training, workouts >4 hours a day)
  • Consume soda or energy drinks of any amount
  • Consume fast food equal to or greater than 5 days per week
  • Consume greater than one serving of alcohol per day
  • (1 serving of wine = 6 oz, 1 serving of beer = 12 oz, 1 serving of spirits = 1 oz)
  • On a carbohydrate-restricted or "Paleo" diet, or calorie-restricted diet (less than 20-25% of maintenance calories)
  • Adults unable to consent
  • Prisoners

研究组 & 干预措施

Experimental Supplement 1

Experimental

6 subjects will consume 12 grams of dietary supplement 1 daily for 4 weeks

干预措施: Monosaccharide Powder (Dietary Supplement)

Experimental Supplement 2

Experimental

6 subjects will consume 12 grams of dietary supplement 2 daily for 4 weeks

干预措施: Monosaccharide Powder (Dietary Supplement)

Experimental Supplement 3

Experimental

20 subjects will consume 50 grams of dietary supplement 3 daily for 4 weeks

干预措施: Monosaccharide Powder (Dietary Supplement)

Placebo Comparator 1

Placebo Comparator

6 subjects will consume 12 grams of placebo dietary supplement daily for 4 weeks

干预措施: Placebo Comparator (Dietary Supplement)

Placebo Comparator 2

Placebo Comparator

6 subjects will consume 50 grams of placebo dietary supplement daily for 4 weeks

干预措施: Placebo Comparator (Dietary Supplement)

结局指标

主要结局

Characterize Immunoglobulin fragment crystallization modifications

时间窗: 4 Weeks

Use mass spectrometry and RNA sequencing from subject blood samples to characterize site specific glycosylation on Immunoglobulin A, Immunoglobulin M, and Immunoglobulin G.

次要结局

  • Quantification of enzymatic modifications measured in grams by spectrometry(6 months)
  • Transcriptome analysis to determine the effect of dietary supplementation on the immune system(6 months)
  • Assess for potential adverse events(2 months after first dose)
  • Flow cytometry to determine the effect of dietary supplementation on the immune system(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验